Relative efficacy of lasmiditan versus rimegepant and ubrogepant as acute treatments for migraine: network meta-analysis findings

BACKGROUND: In the absence of head-to-head trials, comprehensive evidence comparing onset of efficacy of novel agents for acute treatment of migraine is lacking. This study aimed to explore the relative efficacy of lasmiditan (serotonin [5-hydroxytryptamine] 1F receptor agonist) versus rimegepant an...

Descripción completa

Detalles Bibliográficos
Autores principales: Polavieja, Pepa, Belger, Mark, Venkata, Shiva Kumar, Wilhelm, Stefan, Johansson, Erin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Milan 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9258126/
https://www.ncbi.nlm.nih.gov/pubmed/35790906
http://dx.doi.org/10.1186/s10194-022-01440-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9258126/
https://www.ncbi.nlm.nih.gov/pubmed/35790906
http://dx.doi.org/10.1186/s10194-022-01440-w

Ejemplares similares